News Daily News RE-VERSE AD: Dabigatran Antidote Appears Safe, Effective in Interim Analysis June 25, 2015
News Industry News Portola Pharmaceuticals Announces In Vivo Study Results Demonstrating Andexanet Alfa Significantly Reduced Bleeding and Reversed Anticoagulation Activity of Rivaroxaban While Four-Factor Prothrombin C June 25, 2015
Presentation RE-VERSE AD: Idarucizumab for Dabigatran Reversal Presenter: Charles V. Pollack Jr June 24, 2015
News Daily News Meta-analysis Supports Endovascular Therapy for Acute Stroke Nicole Lou June 23, 2015
News Daily News Meta-analysis Supports Endovascular Therapy for Acute Stroke Nicole Lou June 23, 2015
News Daily News En Análisis ACCOAST Identifica los Factores asociados a Más Riesgos Hemorrágicos en el Manejo de Cuadros de SCASEST Todd Neale June 22, 2015
News Daily News ACCOAST Analysis Identifies Factors Tied to Higher Bleeding Risks in NSTE-ACS Todd Neale June 22, 2015
Presentation Predictors of Bleeding in ACS Patients Treated With Prasugrel Presenter: P. Widimsky June 19, 2015
News Industry News New Cost Effectiveness Model Underlines Scope of Polypill Strategy to Prevent Recurring Cardiovascular Events and for More Efficient Use of Health Budgets June 19, 2015
News Daily News El Posible Riesgo Cardiovascular de los IBP se Mantiene en 2 Nuevos Estudios June 18, 2015
Presentation CCVVC 2015 Top 10 Advances of Interventional Cardiology 2014 Presenter: Samin K Sharma June 17, 2015
Presentation CCVVC 2015 Data for Recent Antiplatelets and Antithrombotics Presenter: Deepak L. Bhatt June 17, 2015
Presentation Concomitant PPI Use, Platelet Activity, and Clinical Outcomes in ACS Patients Treated With Prasugrel vs Clopidogrel and Managed Without Revascularization Presenter: Jose Carlos Nicolau June 17, 2015